A systematic review and quantitative synthesis of the long-term psychiatric sequelae of pediatric autoimmune

Linda Nguyen1, Jennifer H Yang1, Sajan Goyal2

  • 1Department of Neurosciences, University of California San Diego, San Diego, CA, USA; Division of Neurology, Rady Children's Hospital San Diego, San Diego, CA, USA.

Insights

Long-term psychiatric symptoms affect over one-third of children after autoimmune encephalitis (AE). Factors like abnormal EEG and cognitive issues are linked to these persistent challenges in pediatric AE patients.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Immunology

Background:

  • Long-term neuropsychiatric outcomes of autoimmune encephalitis (AE) are understudied, especially in pediatric cases.
  • Pediatric-onset AE can lead to persistent psychiatric symptoms, impacting quality of life.
  • Understanding these sequelae is crucial for effective patient management and support.

Purpose of the Study:

  • To synthesize published data on ongoing psychiatric symptoms in pediatric-onset AE.
  • To examine associations between acute treatment and long-term psychiatric outcomes.
  • To identify factors contributing to persistent mental health issues post-AE.

Main Methods:

  • Systematic literature search of PubMed, PyscINFO, and Web of Science databases up to August 2021.
  • Analysis of 29 identified studies and quantitative synthesis of patient data.
  • Univariate logistic regression to identify associations with psychiatric symptoms.

Main Results:

  • Over half (52.4%) of pediatric AE cases had persistent symptoms, with 36.0% experiencing psychiatric symptoms long-term.
  • 36.3% of pediatric anti-NMDAR AE patients showed ongoing psychiatric symptoms.
  • Abnormal initial EEG, specific immunotherapies, and persistent cognitive impairments were associated with ongoing psychiatric symptoms.

Conclusions:

  • Chronic psychiatric and behavioral problems persist in a significant portion of children post-AE.
  • Further large-scale prospective studies with standardized assessments are needed.
  • Investigating the impact of clinical features and immunotherapies on long-term mental health is essential.
Abstract